Countouriotis Athena
CIK: 0001571469
Director
Primary company: Turning Point Therapeutics, Inc. (TPTX)
Countouriotis Athena is a corporate insider at Turning Point Therapeutics, Inc. (TPTX) filing SEC Form 4 transactions. 92 transactions across 8 companies, totaling $1,225,910 in purchases and $8,356,885 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 90,316 | - | - | 90,316 | 6/16/2026 Filed: 6/16/2026 | Filing → | |
| Award | 7,490 | - | - | 21,040 | 6/2/2026 Filed: 6/2/2026 | Filing → | |
| Award | 67,546 | - | - | 67,546 | 6/13/2025 Filed: 6/17/2025 | Filing → | |
| Award | 201,857 | - | - | 201,857 | 5/28/2025 Filed: 5/30/2025 | Filing → | |
| Award | 6,650 | - | - | 13,550 | 5/20/2025 Filed: 5/22/2025 | Filing → | |
| Award | 49,303 | - | - | 49,303 | 6/11/2024 Filed: 6/13/2024 | Filing → | |
| Award | 47,693 | - | - | 47,693 | 5/21/2024 Filed: 5/23/2024 | Filing → | |
| Award | 4,720 | - | - | 6,900 | 5/21/2024 Filed: 5/23/2024 | Filing → | |
| Award | 50,000 | - | - | 50,000 | 3/1/2024 Filed: 3/5/2024 | Filing → | |
| Award | 2,180 | $0.00 | $0 | 2,180 | 12/27/2023 Filed: 12/28/2023 | Filing → | |
| Award | 51,955 | $0.00 | $0 | 51,955 | 6/6/2023 Filed: 6/8/2023 | Filing → | |
| Award | 24,000 | $0.00 | $0 | 24,000 | 5/25/2023 Filed: 5/26/2023 | Filing → | |
Turning Point Therapeutics, Inc. TPTX | Disposition | 224,640 | - | - | 0 | 8/17/2022 Filed: 8/17/2022 | Filing → |
Turning Point Therapeutics, Inc. TPTX | Disposition | 101,775 | - | - | 0 | 8/17/2022 Filed: 8/17/2022 | Filing → |
Turning Point Therapeutics, Inc. TPTX | Disposition | 325,000 | - | - | 0 | 8/17/2022 Filed: 8/17/2022 | Filing → |
Turning Point Therapeutics, Inc. TPTX | Disposition | 155,844 | - | - | 0 | 8/17/2022 Filed: 8/17/2022 | Filing → |
Turning Point Therapeutics, Inc. TPTX | Disposition | 989,971 | - | - | 0 | 8/17/2022 Filed: 8/17/2022 | Filing → |
Turning Point Therapeutics, Inc. TPTX | Disposition | 67,575 | - | - | 0 | 8/17/2022 Filed: 8/17/2022 | Filing → |
Turning Point Therapeutics, Inc. TPTX | Disposition | 173,389 | - | - | 0 | 8/17/2022 Filed: 8/17/2022 | Filing → |
Turning Point Therapeutics, Inc. TPTX | Disposition | 110,959 | $76.00 | $8.43M | 0 | 8/17/2022 Filed: 8/17/2022 | Filing → |
Type
Award
Shares
90,316
Price
-
Value
-
Type
Award
Shares
7,490
Price
-
Value
-
Type
Award
Shares
67,546
Price
-
Value
-
Type
Award
Shares
201,857
Price
-
Value
-
Type
Award
Shares
6,650
Price
-
Value
-
Type
Award
Shares
49,303
Price
-
Value
-
Type
Award
Shares
47,693
Price
-
Value
-
Type
Award
Shares
4,720
Price
-
Value
-
Type
Award
Shares
50,000
Price
-
Value
-
Type
Award
Shares
2,180
Price
$0.00
Value
$0
Type
Award
Shares
51,955
Price
$0.00
Value
$0
Type
Award
Shares
24,000
Price
$0.00
Value
$0
Turning Point Therapeutics, Inc.
TPTX
Type
Disposition
Shares
224,640
Price
-
Value
-
Turning Point Therapeutics, Inc.
TPTX
Type
Disposition
Shares
101,775
Price
-
Value
-
Turning Point Therapeutics, Inc.
TPTX
Type
Disposition
Shares
325,000
Price
-
Value
-
Turning Point Therapeutics, Inc.
TPTX
Type
Disposition
Shares
155,844
Price
-
Value
-
Turning Point Therapeutics, Inc.
TPTX
Type
Disposition
Shares
989,971
Price
-
Value
-
Turning Point Therapeutics, Inc.
TPTX
Type
Disposition
Shares
67,575
Price
-
Value
-
Turning Point Therapeutics, Inc.
TPTX
Type
Disposition
Shares
173,389
Price
-
Value
-
Turning Point Therapeutics, Inc.
TPTX
Type
Disposition
Shares
110,959
Price
$76.00
Value
$8.43M
AI Agent
Try asking...